Guy Tellier

1.7k total citations
13 papers, 617 citations indexed

About

Guy Tellier is a scholar working on Epidemiology, Microbiology and Otorhinolaryngology. According to data from OpenAlex, Guy Tellier has authored 13 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 7 papers in Microbiology and 4 papers in Otorhinolaryngology. Recurrent topics in Guy Tellier's work include Pneumonia and Respiratory Infections (11 papers), Bacterial Infections and Vaccines (7 papers) and Respiratory viral infections research (4 papers). Guy Tellier is often cited by papers focused on Pneumonia and Respiratory Infections (11 papers), Bacterial Infections and Vaccines (7 papers) and Respiratory viral infections research (4 papers). Guy Tellier collaborates with scholars based in United States, Canada and France. Guy Tellier's co-authors include Guy Boivin, Jean Maziade, Isabelle Hardy, Lala M. Dunbar, Bruno Leroy, Karlis Pauksens, Stephen J. Sharp, Kevin R. Murphy, Richard W. Watts and Manickam Rangaraju and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Guy Tellier

13 papers receiving 591 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guy Tellier United States 10 541 139 75 47 44 13 617
Jacqueline Sánchez United States 9 287 0.5× 56 0.4× 29 0.4× 44 0.9× 36 0.8× 20 402
J.J. Picazo Spain 11 178 0.3× 144 1.0× 60 0.8× 31 0.7× 32 0.7× 27 325
Joseph J. Klimek United States 13 189 0.3× 257 1.8× 41 0.5× 55 1.2× 45 1.0× 20 561
S. Hopkins United States 9 246 0.5× 74 0.5× 37 0.5× 83 1.8× 26 0.6× 11 508
Chabela Peña United States 7 211 0.4× 56 0.4× 30 0.4× 42 0.9× 33 0.8× 12 293
Jesús M Feris United States 13 542 1.0× 71 0.5× 92 1.2× 182 3.9× 110 2.5× 21 736
W. John Spicer Australia 13 107 0.2× 145 1.0× 69 0.9× 112 2.4× 70 1.6× 34 469
Gerard Notario United States 19 717 1.3× 372 2.7× 345 4.6× 67 1.4× 39 0.9× 32 909
M J Ossi United States 11 508 0.9× 227 1.6× 53 0.7× 122 2.6× 28 0.6× 12 669
Yi‐Chuan Huang Taiwan 14 236 0.4× 179 1.3× 39 0.5× 36 0.8× 28 0.6× 26 497

Countries citing papers authored by Guy Tellier

Since Specialization
Citations

This map shows the geographic impact of Guy Tellier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy Tellier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy Tellier more than expected).

Fields of papers citing papers by Guy Tellier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guy Tellier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy Tellier. The network helps show where Guy Tellier may publish in the future.

Co-authorship network of co-authors of Guy Tellier

This figure shows the co-authorship network connecting the top 25 collaborators of Guy Tellier. A scholar is included among the top collaborators of Guy Tellier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guy Tellier. Guy Tellier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Whitley, Richard J., Simon Carson, Essack Mitha, et al.. (2014). Single dose Peramivir for the Treatment of Acute Seasonal Influenza: Integrated Analysis of Efficacy and Safety from Two Placebo-Controlled Trials. Antiviral Therapy. 20(7). 709–719. 22 indexed citations
3.
Carbon, C, Lars Hagberg, Charles Fogarty, et al.. (2006). Clinical and bacteriologic efficacy of telithromycin in patients with bacteremic community-acquired pneumonia. Respiratory Medicine. 100(4). 577–585. 8 indexed citations
4.
Roos, Kees-Peter de, et al.. (2005). Bacteriological efficacy of 5-day therapy with telithromycin in acute maxillary sinusitis. International Journal of Antimicrobial Agents. 25(3). 237–246. 2 indexed citations
5.
Tellier, Guy, Stephen Brunton, & Roomi Nusrat. (2005). Telithromycin for the Treatment of Acute Bacterial Maxillary Sinusitis: A Review of a New Antibacterial Agent. Southern Medical Journal. 98(9). 863–868. 9 indexed citations
6.
Fogarty, Charles, Marcus Zervos, Guy Tellier, et al.. (2005). Telithromycin for the treatment of acute exacerbations of chronic bronchitis. International Journal of Clinical Practice. 59(3). 296–305. 5 indexed citations
7.
8.
Tellier, Guy, et al.. (2004). Comparison of hospitalization rates in patients with community-acquired pneumonia treated with telithromycin for 5 or 7 days or clarithromycin for 10 days. Current Medical Research and Opinion. 20(5). 739–747. 19 indexed citations
9.
Roos, Kees-Peter de, et al.. (2004). Clinical and bacteriological efficacy of 5-day telithromycin in acute maxillary sinusitis: a pooled analysis. Journal of Infection. 50(3). 210–220. 16 indexed citations
10.
11.
Tellier, Guy, et al.. (2003). Efficacy and Tolerability of Telithromycin for 5 or 10 Days vs Amoxicillin/Clavulanic Acid for 10 days in Acute Maxillary Sinusitis. Ear Nose & Throat Journal. 82(8). 576–590. 44 indexed citations
12.
Boivin, Guy, Isabelle Hardy, Guy Tellier, & Jean Maziade. (2000). Predicting Influenza Infections during Epidemics with Use of a Clinical Case Definition. Clinical Infectious Diseases. 31(5). 1166–1169. 262 indexed citations
13.
Murphy, Kevin R., et al.. (2000). Efficacy and Safety of Inhaled Zanamivir for the Treatment of Influenza in Patients with Asthma or Chronic Obstructive Pulmonary Disease. Clinical Drug Investigation. 20(5). 337–349. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacqueline Sánchez Breakdown of academic impact, for papers by J.J. Picazo Breakdown of academic impact, for papers by Joseph J. Klimek Breakdown of academic impact, for papers by S. Hopkins Breakdown of academic impact, for papers by Chabela Peña Breakdown of academic impact, for papers by Jesús M Feris Breakdown of academic impact, for papers by W. John Spicer Breakdown of academic impact, for papers by Gerard Notario Breakdown of academic impact, for papers by M J Ossi Breakdown of academic impact, for papers by Yi‐Chuan Huang
Rankless by CCL
2026